Tg Therapeutics (TGTX) Raw Materials (2023 - 2025)

Tg Therapeutics' Raw Materials history runs 3 years deep, the most recent figure standing at $4.1 million for Q3 2025.

• In Q3 2025, Raw Materials rose 134.08% year-over-year to $4.1 million; the TTM figure through Sep 2025 stood at $4.1 million (up 134.08% YoY), while the FY2024 annual figure was $28.2 million, up 327.7% from the prior year.
• Raw Materials for Q3 2025 stood at $4.1 million, down from $4.1 million in the prior quarter.
• The five-year high for Raw Materials was $28.2 million in Q4 2024, with the low at $24000.0 in Q1 2023.
• The 3-year median for Raw Materials is $1.7 million (2024), against an average of $4.9 million.
• Peak annual rise in Raw Materials reached 7129.17% in 2024, while the deepest fall reached 41.21% in 2024.
• Tg Therapeutics' Raw Materials stood at $6.6 million in 2023, then surged by 327.7% to $28.2 million in 2024, then slumped by 85.58% to $4.1 million in 2025.
• Business Quant data shows TGTX's Raw Materials at $4.1 million in Q3 2025, $4.1 million in Q2 2025, and $4.1 million in Q1 2025.